These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 21429721

  • 1. Is left ventricular hypertrophy a low-level inflammatory state? A population-based cohort study.
    Bo S, Mandrile C, Milanesio N, Pagani A, Gentile L, Gambino R, Villois P, Ghinamo L, Canil S, Durazzo M, Cassader M, Cavallo-Perin P.
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):668-76. PubMed ID: 21429721
    [Abstract] [Full Text] [Related]

  • 2. Sex-differences in prevalence of electrocardiographic left ventricular hypertrophy in Type 2 diabetes: the Casale Monferrato Study.
    Bruno G, Giunti S, Bargero G, Ferrero S, Pagano G, Perin PC.
    Diabet Med; 2004 Aug; 21(8):823-8. PubMed ID: 15270784
    [Abstract] [Full Text] [Related]

  • 3. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B, Losartan Intervention for Endpoint reduction in hypertension Study Investigations.
    Circulation; 2003 Aug 12; 108(6):684-90. PubMed ID: 12885747
    [Abstract] [Full Text] [Related]

  • 4. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM.
    J Electrocardiol; 2009 Aug 12; 42(6):584-8. PubMed ID: 19631946
    [Abstract] [Full Text] [Related]

  • 5. Relation between abdominal obesity, insulin resistance and left ventricular hypertrophy diagnosed by electrocardiogram and magnetic resonance imaging in hypertensive patients.
    Vernooij JW, Cramer MJ, Visseren FL, Korndewal MJ, Bots ML, Meijs MF, Doevendans PA, Spiering W, Smart Study Group.
    Am J Cardiol; 2012 Jul 15; 110(2):227-33. PubMed ID: 22483385
    [Abstract] [Full Text] [Related]

  • 6. Hyperleptinemia is associated with hypertension, systemic inflammation and insulin resistance in overweight but not in normal weight men.
    Galletti F, D'Elia L, De Palma D, Russo O, Barba G, Siani A, Miller MA, Cappuccio FP, Rossi G, Zampa G, Strazzullo P.
    Nutr Metab Cardiovasc Dis; 2012 Mar 15; 22(3):300-6. PubMed ID: 21920718
    [Abstract] [Full Text] [Related]

  • 7. Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients.
    Verdecchia P, Sleight P, Avanzini F, de Simone G, Pede S, Perticone F, Schillaci G, Vanuzzo D, Angeli F, Reboldi GP, Maggioni AP.
    Ital Heart J; 2003 Jul 15; 4(7):479-83. PubMed ID: 14558300
    [Abstract] [Full Text] [Related]

  • 8. Electrocardiographic left ventricular hypertrophy and arterial stiffness: the Ohasama study.
    Watabe D, Hashimoto J, Hatanaka R, Hanazawa T, Ohba H, Ohkubo T, Kikuya M, Totsune K, Imai Y.
    Am J Hypertens; 2006 Dec 15; 19(12):1199-205. PubMed ID: 17161763
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR, Cea-Calvo L, Bertomeu V, Aznar J, for Investigators study VIIDA.
    Rev Esp Cardiol; 2007 Feb 15; 60(2):148-56. PubMed ID: 17338880
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence and determinants of electrocardiographic left ventricular hypertrophy among a multiethnic population of postmenopausal women (The Women's Health Initiative).
    Oberman A, Prineas RJ, Larson JC, LaCroix A, Lasser NL.
    Am J Cardiol; 2006 Feb 15; 97(4):512-9. PubMed ID: 16461048
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population.
    Barrios V, Escobar C, Calderon A, Ribas L, Marti D, Asin E.
    Blood Press; 2008 Feb 15; 17(2):110-5. PubMed ID: 18568700
    [Abstract] [Full Text] [Related]

  • 17. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
    Lozano JV, Redón J, Cea-Calvo L, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J.
    Rev Esp Cardiol; 2006 Feb 15; 59(2):136-42. PubMed ID: 16540035
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. What predicts the occurrence of the metabolic syndrome in a population-based cohort of adult healthy subjects?
    Bo S, Rosato R, Ciccone G, Gambino R, Durazzo M, Gentile L, Cassader M, Cavallo-Perin P, Pagano G.
    Diabetes Metab Res Rev; 2009 Jan 15; 25(1):76-82. PubMed ID: 19145586
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese.
    Wang SX, Xue H, Zou YB, Sun K, Fu CY, Wang H, Hui RT.
    Chin Med J (Engl); 2012 Jan 15; 125(1):21-6. PubMed ID: 22340460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.